Breeding method for preventing and treating African swine fever

By mixing specific plant extracts into pig feed, the resistance of pigs to African swine fever virus is improved, and the high mortality rate and economic losses of African swine fever in farms is solved, thus reducing infection risk and improving The effect of economic gains.

CN118923619AInactive Publication Date: 2024-11-12HUNAN DIWANG BIG WORLD TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411271159.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-11
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing technology cannot effectively prevent and treat African swine fever, resulting in high mortality rates and economic losses in breeding farms, and lack of effective prevention and treatment methods.

Method used

Mix the astragalus extract, Codonopsis pilosula extract, Angelica extract, soybean extract, cork extract and purpura extract in a specific proportion, add it to pig feed, and increase pigs' African swine fever virus by stage feeding. and regularly disinfect in pig houses.

Benefits of technology

It significantly reduces the risk of pigs being infected with the African swine fever virus, increases pigs' resistance to the virus, reduces the harm of the virus to the farm, saves treatment costs, and increases the survival rate and economic benefits of slaughter.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118923619A_ABST
    Figure CN118923619A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of livestock breeding, and discloses a breeding method for preventing and treating African swine fever. The breeding method for preventing and treating African swine fever comprises the following steps: mixing an astragalus extract, a codonopsis pilosula extract, an angelica sinensis extract, a soybean extract, a golden cypress extract, a folium isatidis extract and a herba violae extract to obtain a medicinal preparation; the pharmaceutical preparation is added into the feed for the pigs in the nursing period to feed the pigs in the nursing period. The pharmaceutical preparation is added into the feed for the pigs in the fattening period to feed the pigs in the fattening period. According to the breeding method for preventing and treating African swine fever provided by the invention, the astragalus extract, the codonopsis pilosula extract, the angelica sinensis extract, the soybean extract, the golden cypress extract, the folium isatidis extract and the herba violae extract are added into the conventional feed, so that the risk that pigs are infected with African swine fever viruses can be reduced; the resistance of the pigs to the African swine fever virus is improved, the African swine fever is treated to a certain extent, and the economic benefits of the pig industry are improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of animal husbandry, and in particular to a breeding method for preventing and treating African swine fever. Background Art

[0002] African swine fever (ASF) is an acute, hemorrhagic, and highly contagious animal disease of domestic pigs and wild boars caused by the African swine fever virus (ASFV). The World Organization for Animal Health has listed it as a notifiable animal disease. According to clinical manifestations, African swine fever can be divided into the most acute type, acute type, subacute type, and chronic type. The most acute type of African swine fever is sudden, with no obvious symptoms, and death within 24 to 48 hours; the early stage of acute African swine fever is characterized by depression, loss of appetite, and high fever, and the later stage is characterized by respiratory disorders, serous or mucous nasal secretions, vomiting, diarrhea, etc., and death in about 1 week, with a mortality rate of up to 100%; the symptoms of subacute African swine fever are milder than those of acute African swine fever, and death in about 3 weeks, with a mortality rate of 30% to 70%; chronic African swine fever is characterized by pneumonia, pericarditis, arthritis, etc., and death in about 5 weeks, with a lower mortality rate of 2% to 10%.

[0003] The transmission speed and infection rate of African swine fever are very high. Generally, as long as one pig in a farm is infected with the African swine fever virus, all the pigs in the entire farm will be infected with the African swine fever virus. At present, there is no effective treatment for African swine fever. Therefore, usually, once a pig is found to be infected with the African swine fever virus, compulsory killing measures will be taken, that is, slaughtering the sick pigs and burning and burying the sick pig carcasses; however, such African swine fever treatment measures will cause huge economic losses to the pig farming industry. Therefore, providing a breeding method that can effectively prevent and control African swine fever, reduce the risk of pigs being infected with the African swine fever virus, improve the resistance of pigs to the African swine fever virus, and treat African swine fever to a certain extent has become a technical problem that needs to be urgently solved by technical personnel in this field. Summary of the invention

[0004] The purpose of the present invention is to provide a breeding method for preventing and treating African swine fever, which can reduce the risk of pigs being infected with African swine fever virus, improve the resistance of pigs to African swine fever virus, and treat African swine fever to a certain extent, thereby increasing the economic benefits of the pig farming industry.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] A breeding method for preventing and treating African swine fever comprises the following steps:

[0007] 1) mixing an astragalus extract, a codonopsis extract, an angelica extract, a soybean extract, a phellodendron chinense extract, an isatis indigotica extract, and a viola yedoensis extract to obtain a pharmaceutical preparation;

[0008] 2) adding the pharmaceutical preparation obtained in step 1) to nursery pig feed to obtain nursery pig feed for preventing and treating African swine fever;

[0009] 3) using the nursery pig feed for preventing and treating African swine fever obtained in step 2) to feed the pigs that are about to enter the nursery period until the nursery period ends and they enter the fattening period;

[0010] 4) adding the pharmaceutical preparation obtained in step 1) to fattening pig feed to obtain fattening pig feed for preventing and treating African swine fever;

[0011] 5) Feeding fattening pigs with the fattening pig feed for preventing and treating African swine fever obtained in step 4) until the end of the fattening period.

[0012] Furthermore, in step 1), the extraction method of the astragalus extract comprises the following steps: using 50% ethanol as a solvent, with a solid-liquid ratio of astragalus to 50% ethanol of 1:10, reflux extraction at 60°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the astragalus extract.

[0013] Furthermore, in step 1), the extraction method of the Codonopsis pilosula extract comprises the following steps: using 75% ethanol as solvent, with a solid-liquid ratio of Codonopsis pilosula to 75% ethanol of 1:10, reflux extraction at 80°C for 1 hour, then concentrating by rotary evaporation, and drying to obtain the Codonopsis pilosula extract.

[0014] Furthermore, in step 1), the extraction method of the angelica extract comprises the following steps: using 65% ethanol as solvent, with a solid-liquid ratio of angelica to 65% ethanol of 1:15, reflux extraction at 60°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the angelica extract.

[0015] Furthermore, in step 1), the extraction method of the soybean extract comprises the following steps: using 75% ethanol as solvent, with a solid-liquid ratio of soybean to 75% ethanol of 1:20, reflux extraction at 55°C for 2 hours, then concentrating by rotary evaporation, and drying to obtain the soybean extract.

[0016] Furthermore, in step 1), the extraction method of the Phellodendron chinense extract comprises the following steps: using 45% ethanol as solvent, with a solid-liquid ratio of Phellodendron chinense to 45% ethanol of 1:15, reflux extraction at 70°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the Phellodendron chinense extract.

[0017] Furthermore, in step 1), the extraction method of the isatis indigotica extract comprises the following steps: using 75% ethanol as solvent, according to the solid-liquid ratio of isatis indigotica to 75% ethanol being 1:10, reflux extraction at 65°C for 1.2h, then concentrating by rotary evaporation, and drying to obtain the isatis indigotica extract.

[0018] Furthermore, in step 1), the extraction method of the Viola yedoensis extract comprises the following steps: using 20% ​​ethanol as solvent, according to the solid-liquid ratio of Viola yedoensis to 20% ethanol being 1:10, reflux extraction at 40°C for 3 hours, then concentrating by rotary evaporation, and drying to obtain the Viola yedoensis extract.

[0019] Furthermore, in step 1), the mass ratio of the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and viola yedoensis extract is 1:(2-4):(2-4):(4-6):(1-3):(2-4):(0.5-1.5);

[0020] Preferably, the mass ratio of the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and Viola yedoensis extract is 1:3:3:5:2:3:1.

[0021] Furthermore, in step 2), the mass ratio of the nursery pig feed to the drug preparation is (80-100):1.

[0022] Furthermore, in step 3), the feeding is carried out according to a feeding amount of (body weight×0.02) / day.

[0023] Furthermore, in step 4), the mass ratio of the fattening pig feed to the pharmaceutical preparation is (40-50):1.

[0024] Furthermore, in step 5), the feeding is carried out according to a feeding amount of (body weight×0.04) / day.

[0025] Furthermore, during the entire breeding process, it is necessary to remove feces and waste from the pig house every 3 to 5 days, and spray 1% potassium persulfate solution to disinfect the pig house.

[0026] Compared with the prior art, the present invention has the following beneficial effects:

[0027] The present invention provides a breeding method for preventing and treating African swine fever, which can reduce the risk of pigs being infected with African swine fever virus, improve the resistance of pigs to African swine fever virus, treat African swine fever to a certain extent, and improve the economic benefits of the pig farming industry by adding astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and Viola yedoensis extract to conventional feed;

[0028] The astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract provided by the present invention have a synergistic effect. Compared with a single extract or a mixture of several extracts, the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract are mixed in a mass ratio of 1: (2-4): (2-4): (4-6): (1-3): (2-4): (0.5-1.5), which has the best African swine fever virus inhibition effect;

[0029] The breeding method for preventing and treating African swine fever provided by the present invention can achieve cost reduction and efficiency improvement. Specifically, firstly, the present invention saves feed costs to the greatest extent while effectively reducing the risk of pigs being infected with African swine fever virus through staged feeding; secondly, the feed provided by the present invention has the function of preventing and treating African swine fever, can reduce the harm caused by African swine fever virus to farms, and save treatment costs; finally, the breeding method provided by the present invention can improve the survival rate and weight of pigs. It has been found through actual implementation that a single pig can increase the income of a farm by 1,000 to 5,000 yuan. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Various other advantages and benefits will become apparent to those of ordinary skill in the art by reading the detailed description of the preferred embodiments below. The accompanying drawings are only for the purpose of illustrating the preferred embodiments and are not to be considered as limiting the present invention. Moreover, the same reference symbols are used throughout the accompanying drawings to represent the same components. In the accompanying drawings:

[0031] Figure 1 This is a test result of the inhibitory effect of a single extract on African swine fever virus;

[0032] Figure 2 This is a graph showing the results of the inhibition of mixed extracts 1 to 19 on African swine fever virus;

[0033] Figure 3 This is a graph showing the results of the test of the inhibitory effect of mixed extracts 20 to 38 on African swine fever virus;

[0034] Figure 4 This is a graph showing the results of the test of the inhibitory effect of mixed extracts 39-57 on African swine fever virus;

[0035] Figure 5 This is a graph showing the results of the test of the inhibitory effect of mixed extracts 58-76 on African swine fever virus;

[0036] Figure 6 This is a graph showing the results of the test of the inhibitory effect of mixed extracts 77-95 on African swine fever virus;

[0037] Figure 7 This is a graph showing the results of the test of the inhibitory effect of mixed extracts 96-114 on African swine fever virus;

[0038] Figure 8 The figure is a test result of the inhibitory effect of mixed extract 114 in different proportions on African swine fever virus;

[0039] Fig. 9 The body temperature changes of mice. DETAILED DESCRIPTION

[0040] Various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as limiting the present invention, but should be understood as a more detailed description of certain aspects, features, and embodiments of the present invention.

[0041] It should be understood that the terms described in the present invention are only for describing special embodiments and are not intended to limit the present invention. In addition, for the numerical range in the present invention, it should be understood that each intermediate value between the upper and lower limits of the scope is also specifically disclosed. Each smaller range between the intermediate value in any stated value or stated range and any other stated value or intermediate value in the described range is also included in the present invention. The upper and lower limits of these smaller ranges can be independently included or excluded in the scope.

[0042] Unless otherwise indicated, all technical and scientific terms used herein have the same meanings as those generally understood by those skilled in the art. Although the present invention describes only preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the implementation or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and / or materials associated with the documents. In the event of a conflict with any incorporated document, the content of this specification shall prevail.

[0043] It will be apparent to those skilled in the art that various modifications and variations may be made to the specific embodiments of the present invention description without departing from the scope or spirit of the present invention. Other embodiments derived from the present invention description will be apparent to the skilled artisan. The present invention description and examples are exemplary only.

[0044] The words “include,” “including,” “have,” “contain,” etc. used in this document are open-ended terms, meaning including but not limited to.

[0045] In the following examples and comparative examples, the room temperature is 25±2°C.

[0046] In the following examples and comparative examples, unless otherwise specified, the extraction method of the astragalus extract comprises the following steps: using 50% ethanol as a solvent, with a solid-liquid ratio of astragalus to 50% ethanol of 1:10, reflux extraction at 60°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the astragalus extract.

[0047] In the following embodiments and comparative examples, unless otherwise specified, the extraction method of the Codonopsis pilosula extract comprises the following steps: using 75% ethanol as a solvent, with a solid-liquid ratio of Codonopsis pilosula to 75% ethanol of 1:10, reflux extraction at 80°C for 1 hour, then concentrating by rotary evaporation, and drying to obtain the Codonopsis pilosula extract.

[0048] In the following examples and comparative examples, unless otherwise specified, the method for extracting the angelica extract comprises the following steps: using 65% ethanol as a solvent, with a solid-liquid ratio of angelica to 65% ethanol of 1:15, reflux extraction at 60°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the angelica extract.

[0049] In the following examples and comparative examples, unless otherwise specified, the method for extracting the soybean extract comprises the following steps: using 75% ethanol as a solvent, with a solid-liquid ratio of soybean to 75% ethanol of 1:20, reflux extraction at 55°C for 2h, then concentrating by rotary evaporation, and drying to obtain the soybean extract.

[0050] In the following examples and comparative examples, unless otherwise specified, the extraction method of the Phellodendron chinense extract comprises the following steps: using 45% ethanol as a solvent, with a solid-liquid ratio of Phellodendron chinense to 45% ethanol of 1:15, reflux extraction at 70°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the Phellodendron chinense extract.

[0051] In the following embodiments and comparative examples, unless otherwise specified, the extraction method of the isatis indigotica extract comprises the following steps: using 75% ethanol as a solvent, according to a solid-liquid ratio of isatis indigotica to 75% ethanol of 1:10, reflux extraction at 65°C for 1.2h, then concentrating by rotary evaporation, and drying to obtain the isatis indigotica extract.

[0052] In the following examples and comparative examples, unless otherwise specified, the method for extracting the Viola yedoensis extract comprises the following steps: using 20% ​​ethanol as a solvent, with a solid-liquid ratio of Viola yedoensis to 20% ethanol of 1:10, reflux extraction at 40°C for 3h, then concentrating by rotary evaporation, and drying to obtain the Viola yedoensis extract.

[0053] In the following examples and comparative examples, the nursery period refers to pigs from 1 month to 3 months old, and the fattening period refers to pigs from 3 months old to marketed;

[0054] In the following examples and comparative examples, the nursery pig feed is 30% suckling pig nursery feed purchased from Tianjin Zhengbang Feed Co., Ltd. Those skilled in the art can choose other nursery pig feeds that do not have the effect of preventing and treating African swine fever for feeding according to actual conditions;

[0055] In the following examples and comparative examples, the fattening pig feed is concentrated feed for growing pigs purchased from Tianjin Zhengbang Feed Co., Ltd. Those skilled in the art can choose other fattening pig feeds that do not have the function of preventing and treating African swine fever for feeding according to actual conditions.

[0056] In the following embodiments, a breeding method for preventing and treating African swine fever comprises the following steps:

[0057] 1) mixing the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract in a mass ratio of 1:(2-4):(2-4):(4-6):(1-3):(2-4):(0.5-1.5) to obtain a pharmaceutical preparation;

[0058] 2) adding the pharmaceutical preparation obtained in step 1) to the nursery pig feed according to a mass ratio of nursery pig feed to the pharmaceutical preparation of (80-100):1 to obtain a nursery pig feed for preventing and treating African swine fever;

[0059] 3) feeding the pigs about to enter the nursery period with the nursery pig feed for preventing and treating African swine fever obtained in step 2) at a feeding rate of (body weight × 0.02) / day until the nursery period ends and the pigs enter the fattening period;

[0060] 4) adding the drug preparation obtained in step 1) to the fattening pig feed according to a mass ratio of the fattening pig feed to the drug preparation of (40-50):1, to obtain a fattening pig feed for preventing and treating African swine fever;

[0061] 5) feeding the pigs entering the fattening period in step 3) with the fattening pig feed for preventing and treating African swine fever obtained in step 4) at a feeding amount of (body weight × 0.04) / day, and the fattening period ends;

[0062] In addition, during the entire breeding process, feces and waste in the pig house must be removed every 3 to 5 days, and 1% potassium persulfate solution must be sprayed to disinfect the pig house.

[0063] 1. Inhibitory effect of the extract on African swine fever virus

[0064] 1. Inhibitory effect of single extract on African swine fever virus

[0065] According to the mass volume ratio of astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract or Viola yedoensis extract to 60% ethanol being 10g:1L, astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract or Viola yedoensis extract are added to 60% ethanol, and shaken well to obtain astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and Viola yedoensis extract;

[0066] According to 5×10 5 / well, inoculate PAM cells (porcine alveolar macrophages) on the cell plate, and culture them in a cell culture incubator at 37°C and 5% CO2. When the PAM cells are attached to the wall, infect the PAM monolayer cells in the cell plate with 2MOI of African swine fever virus. After 90 minutes, the supernatant virus solution is aspirated and 60% ethanol, astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract or Viola yedoensis extract are added respectively. Then, the cell plate is placed in a cell culture incubator at 37°C and 5% CO2 for further incubation. After 72 hours, the cell plate is repeatedly frozen and thawed three times at -80°C and 4°C to fully lyse the cells, collect the supernatant, and refer to T / CVMA5-2018 "Real-time Fluorescence PCR Detection Method for African Swine Fever Virus" to perform African swine fever virus real-time fluorescence PCR detection on the supernatant to obtain the Ct value of the p72 gene. The Ct value detection result of the p72 gene is as follows Figure 1 As shown;

[0067] Depend on Figure 1 It can be seen that Astragalus extract, Codonopsis pilosula extract, Angelica sinensis extract, soybean extract, Phellodendron chinense extract, Isatis indigotica extract and Viola yedoensis extract all have a certain inhibitory effect on the proliferation of African swine fever virus, but the inhibitory effect is poor. Among them, soybean extract, which has the best inhibitory effect, has a Ct value of only 23.6.

[0068] 2. Inhibitory effect of the composite extract on African swine fever virus

[0069] According to the types of extracts listed in Table 1, the extracts were mixed in equal mass ratios to obtain mixed extracts 1 to 114;

[0070] Table 1 Extract types

[0071]

[0072]

[0073]

[0074]

[0075] According to the mass volume ratio of the mixed extract to 60% ethanol being 10 g:1 L, the mixed extracts 1 to 114 were added to 60% ethanol, and the mixture was shaken to obtain mixed extracts 1 to 114;

[0076] According to 5×10 5 / well, inoculate PAM cells on the cell plate, and culture them in a cell culture incubator at 37°C and 5% CO2. When the PAM cells adhere to the wall, infect the PAM monolayer cells in the cell plate with 2MOI of African swine fever virus. After 90 minutes, aspirate the supernatant virus solution and add mixed extracts 1 to 114 respectively. Then, place the cell plate in a cell culture incubator at 37°C and 5% CO2 for further incubation. After 72 hours, freeze and thaw the cell plate three times at -80°C and 4°C to fully lyse the cells, collect the supernatant, and perform African swine fever virus real-time fluorescence PCR detection on the supernatant with reference to T / CVMA5-2018 "African swine fever virus real-time fluorescence PCR detection method" to obtain the Ct value of the p72 gene. The Ct value detection result of the p72 gene is shown as follows Figures 2 to 7 As shown;

[0077] Depend on Figures 2 to 7 It can be seen that the 114 mixed extracts all have a certain inhibitory effect on the proliferation of African swine fever virus. Among them, mixed extract 51, mixed extract 82 and mixed extract 114 have better inhibitory effects on African swine fever virus, and the Ct values ​​can reach 29.8, 29.6 and 30.1, respectively.

[0078] 3. Inhibitory effects of mixed extract 114 in different proportions on African swine fever virus

[0079] The astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and Viola yedoensis extract were mixed according to the mass ratios recorded in Table 2 to obtain mixed extracts A to M;

[0080] Table 2 Extract mass ratio

[0081]

[0082]

[0083] According to the mass volume ratio of the mixed extract to 60% ethanol being 10 g:1 L, the mixed extracts A to M were added into 60% ethanol and shaken well to obtain mixed extracts A to M;

[0084] According to 5×10 5PAM cells were inoculated on the cell plate and cultured in a cell culture incubator at 37°C and 5% CO2. After the PAM cells adhered to the wall, the PAM monolayer cells in the cell plate were infected with 2MOI of African swine fever virus. After 90 minutes, the supernatant virus solution was aspirated and mixed extracts A to M were added respectively. Then, the cell plate was placed in a cell culture incubator at 37°C and 5% CO2 for further incubation. After 72 hours, the cell plate was repeatedly frozen and thawed three times at -80°C and 4°C to fully lyse the cells, and the supernatant was collected. According to T / CVMA5-2018 "Real-time fluorescence PCR detection method for African swine fever virus", the supernatant was subjected to real-time fluorescence PCR detection of African swine fever virus to obtain the Ct value of the p72 gene. The Ct value detection result of the p72 gene is shown as follows: Figure 3 As shown;

[0085] Depend on Figure 8 It can be seen that 13 mixed extracts 114 in different proportions all have good inhibitory effects on the proliferation of African swine fever virus. Among them, the mixed extract obtained by mixing astragalus extract, codonopsis pilosula extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and Viola yedoensis extract in a mass ratio of 1:3:3:5:2:3:1, namely mixed extract B, has the best African swine fever virus inhibition effect, and the Ct value can reach 30.5.

[0086] 2. The inhibitory effect of drug preparations on African swine fever virus

[0087] 1. Construction of African swine fever model mice

[0088] 1.1 Modeling

[0089] A porcine mouse model was constructed according to patent CN102727880A, and 2 mL 10 2 TCID 50 / mL of African swine fever virus diluent;

[0090] 1.2 Modeling results

[0091] 72 hours after injection of African swine fever virus diluent, the body temperature of the mice increased from 38±0.5℃ to 41.5±0.5℃, their breathing became disordered, and they had serous or mucous nasal secretions. The results of venous blood PCR (polymerase chain reaction) were positive, proving that the African swine fever model mice were successfully constructed.

[0092] 2. Preparation of Experimental Drug Preparations

[0093] 2.1 Low concentration agent

[0094] According to the mass ratio of astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract of 1:3:3:5:2:3:1, astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract are mixed to obtain a pharmaceutical preparation, and then according to the mass volume ratio of the pharmaceutical preparation to normal saline of 10g:1L, the pharmaceutical preparation is added to normal saline, and shaken to obtain a low-concentration agent;

[0095] 2.2 High concentration agents

[0096] According to the mass ratio of astragalus extract, codonopsis pilosula extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and viola yedoensis extract of 1:3:3:5:2:3:1, astragalus extract, codonopsis pilosula extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and viola yedoensis extract are mixed to obtain a pharmaceutical preparation, and then the pharmaceutical preparation is added into physiological saline at a mass volume ratio of the pharmaceutical preparation to physiological saline of 20g:1L, and the mixture is shaken to obtain a high-concentration medicament.

[0097] 3. Grouping and Dosing

[0098] Five healthy 4-week-old porcine mice were selected as the blank control group, and 15 African swine fever model mice successfully constructed in step 1 (mice 0 hours after injection of African swine fever virus diluent) were randomly divided into 3 groups, namely the positive control group, the low-concentration drug group and the high-concentration drug group (each mouse was raised separately);

[0099] Blank control group: 0.5 mL of normal saline was administered intragastrically every day;

[0100] Positive control group: On the first day of the experiment, 2 mL of 10 2 TCID 50 / mL of African swine fever virus diluent, followed by daily intragastric administration of 0.5mL of normal saline;

[0101] Low concentration group: On the first day of the experiment, 2 mL 10 2 TCID 50 / mL of African swine fever virus diluent, followed by oral administration of 0.5mL of low-concentration agent every day;

[0102] High concentration group: On the first day of the experiment, 2 mL 10 2 TCID 50 / mL of African swine fever virus diluent, followed by oral administration of 0.5mL of high-concentration agent every day.

[0103] 4. Changes in body temperature

[0104] The experimental period lasted for 7 days. During the experiment, the body temperature of mice in each group was recorded at 20:00 every night. The changes in body temperature are shown in Table 3 and Fig. 9 As shown:

[0105] Table 3 Body temperature changes (℃)

[0106]

[0107] Note: The body temperature of mice is measured according to the average body temperature of mice in each group. If any mice die, the average value is calculated according to the number of surviving mice;

[0108] Body temperature is an important indicator of African swine fever, as shown in Table 3 and Fig. 9 It can be seen that the body temperature of the mice in the blank control group was stable at 38°C, which is the normal body temperature of mice; the body temperature of the mice in the positive control group increased significantly on the third day after the injection of the African swine fever virus diluent, reaching 41.7°C, and body temperature fluctuations occurred on the fourth day, and the body temperature decreased, but did not reach the normal body temperature of mice. From the fifth to the seventh day, the body temperature increased and maintained at 42°C; this indicates that the mice in the positive control group have been infected with African swine fever virus; the body temperature of the low-concentration agent group and the high-concentration agent group increased on the third day after the injection of the African swine fever virus diluent, but compared with the positive control group, the temperature increase was not significant, and the body temperature of the mice continued to increase on the fourth day, stabilizing at 40.9°C and 39.4°C, respectively. From the fifth day, the body temperature of the mice began to decrease and reached a normal level on the seventh day; this indicates that the pharmaceutical preparation prepared by the present invention has a certain inhibitory effect on African swine fever virus, and the high-concentration pharmaceutical preparation has a better inhibitory effect on African swine fever virus than the low-concentration pharmaceutical preparation.

[0109] 5. PCR detection

[0110] The experimental period was 7 days in total. During the experiment, whole blood was drawn from mice at 20:00 every night, and the upper serum was drawn after centrifugation. The serum was tested for African swine fever virus by PCR. The PCR test results are shown in Table 4;

[0111] Table 4 PCR detection

[0112]

[0113] Note: "+" indicates a positive PCR test result, "-" indicates a negative PCR test result, and "+-" indicates a weakly positive PCR test result;

[0114] PCR detection is the most intuitive indicator of African swine fever. As shown in Table 4, the PCR test results of the blank control group mice were negative throughout the experiment, indicating that there was no African swine fever virus in the serum of the blank control group mice; the PCR test results of the positive control group were positive from the first day after the injection of the African swine fever virus diluent throughout the experiment, indicating that there was a large amount of African swine fever virus in the serum of the positive control group mice; the PCR test result of the low-concentration agent group was weakly positive on the first day after the injection of the African swine fever virus diluent, excluding the possibility of serum contamination, indicating that the African swine fever virus content in the serum of the low-concentration agent group mice was low on the first day after the injection of the African swine fever virus diluent, and on the second day thereafter The PCR test results were positive on the 2nd to 5th day, and weakly positive on the 6th to 7th day, which shows that the pharmaceutical preparation prepared by the present invention has a certain inhibitory effect on African swine fever virus; the PCR test result of the high-concentration pharmaceutical group on the first day after the injection of the African swine fever virus diluent was weakly positive, excluding the possibility of serum contamination, which shows that the African swine fever virus content in the serum of the mice in the high-concentration pharmaceutical group was low on the first day after the injection of the African swine fever virus diluent, and the PCR test results were positive on the 2nd to 5th day, the PCR test result was weakly positive on the 6th day, and the PCR test result was negative on the 7th day, which shows that the high-concentration pharmaceutical preparation has a better inhibitory effect on African swine fever virus than the low-concentration pharmaceutical preparation.

[0115] 6. Conclusion

[0116] The pharmaceutical preparation provided by the present invention can inhibit African swine fever virus to a certain extent, and a high-concentration pharmaceutical preparation has a better African swine fever virus inhibition effect than a low-concentration pharmaceutical preparation.

[0117] Example 1

[0118] A breeding method for preventing and treating African swine fever

[0119] 1) mixing the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract in a mass ratio of 1:2:2:4:1:2:0.5 to obtain a pharmaceutical preparation;

[0120] 2) adding the pharmaceutical preparation obtained in step 1) to the nursery pig feed at a mass ratio of nursery pig feed to the pharmaceutical preparation of 80:1 to obtain a nursery pig feed for preventing and treating African swine fever;

[0121] 3) feeding the pigs about to enter the nursery period with the nursery pig feed for preventing and treating African swine fever obtained in step 2) at a feeding rate of (body weight × 0.02) / day until the nursery period ends and the pigs enter the fattening period;

[0122] 4) adding the drug preparation obtained in step 1) to the fattening pig feed at a mass ratio of the fattening pig feed to the drug preparation of 40:1 to obtain a fattening pig feed for preventing and treating African swine fever;

[0123] 5) feeding the pigs entering the fattening period in step 3) with the fattening pig feed for preventing and treating African swine fever obtained in step 4) at a feeding amount of (body weight × 0.04) / day until the end of the fattening period;

[0124] In addition, during the entire breeding process, feces and waste in the pig house must be removed every 3 days, and 1% potassium persulfate solution must be sprayed to disinfect the pig house.

[0125] Example 2

[0126] A breeding method for preventing and treating African swine fever

[0127] 1) mixing the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract in a mass ratio of 1:3:3:5:2:3:1 to obtain a pharmaceutical preparation;

[0128] 2) adding the pharmaceutical preparation obtained in step 1) to the nursery pig feed at a mass ratio of nursery pig feed to the pharmaceutical preparation of 90:1 to obtain a nursery pig feed for preventing and treating African swine fever;

[0129] 3) feeding the pigs about to enter the nursery period with the nursery pig feed for preventing and treating African swine fever obtained in step 2) at a feeding rate of (body weight × 0.02) / day until the nursery period ends and the pigs enter the fattening period;

[0130] 4) adding the drug preparation obtained in step 1) to the fattening pig feed at a mass ratio of 45:1 to the drug preparation to obtain a fattening pig feed for preventing and treating African swine fever;

[0131] 5) feeding the pigs entering the fattening period in step 3) with the fattening pig feed for preventing and treating African swine fever obtained in step 4) at a feeding amount of (body weight × 0.04) / day until the end of the fattening period;

[0132] In addition, during the entire breeding process, feces and waste in the pig house must be removed every 3 days, and 1% potassium persulfate solution must be sprayed to disinfect the pig house.

[0133] Example 3

[0134] A breeding method for preventing and treating African swine fever

[0135] 1) mixing the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron extract, isatis indigotica extract and viola yedoensis extract in a mass ratio of 1:4:4:6:3:4:1.5 to obtain a pharmaceutical preparation;

[0136] 2) adding the pharmaceutical preparation obtained in step 1) to the nursery pig feed at a mass ratio of nursery pig feed to the pharmaceutical preparation of 100:1 to obtain a nursery pig feed for preventing and treating African swine fever;

[0137] 3) feeding the pigs about to enter the nursery period with the nursery pig feed for preventing and treating African swine fever obtained in step 2) at a feeding rate of (body weight × 0.02) / day until the nursery period ends and the pigs enter the fattening period;

[0138] 4) adding the drug preparation obtained in step 1) to the fattening pig feed at a mass ratio of 50:1 to the drug preparation to obtain a fattening pig feed for preventing and treating African swine fever;

[0139] 5) feeding the pigs entering the fattening period in step 3) with the fattening pig feed for preventing and treating African swine fever obtained in step 4) at a feeding amount of (body weight × 0.04) / day until the end of the fattening period;

[0140] In addition, during the entire breeding process, feces and waste in the pig house must be removed every 3 days, and 1% potassium persulfate solution must be sprayed to disinfect the pig house.

[0141] Effect verification

[0142] 1. Selection and grouping of test animals

[0143] Three healthy nursery pigs (fed with nursery pig feed for preventing and treating African swine fever for one month) were raised in Examples 1 to 3, respectively, and were recorded as PN-1, PN-2, and PN-3;

[0144] Three healthy nursery pigs fed with nursery pig feed that does not contain drug preparations, recorded as N;

[0145] Three healthy pigs were obtained at the end of the fattening period in each of Examples 1 to 3, and were respectively designated as PF-1, PF-2, and PF-3;

[0146] Three healthy pigs at the end of the fattening period that were fed with the fattening pig feed that did not contain drug preparations, recorded as F;

[0147] To prevent cross infection, each selected test animal must be housed individually;

[0148] 2. Drug administration

[0149] PN-1, PN-2 and PN-3: 10 mL by intragastric administration for 10 2 TCID 50 / mL of African swine fever virus diluent;

[0150] N: Oral administration 10mL 10 2 TCID 50 / mL of African swine fever virus diluent;

[0151] PF-1, PF-2 and PF-3: 10 mL by intragastric administration for 10 3 TCID 50 / mL of African swine fever virus diluent;

[0152] F: Oral administration 10mL 10 3 TCID 50 / mL of African swine fever virus diluent;

[0153] 3. PCR detection

[0154] The experimental period was 7 days in total. During the experiment, whole blood was drawn from pigs at a fixed time (20:00 p.m.) every two days. After centrifugation, the upper serum was drawn and the serum was tested for African swine fever virus by PCR. The PCR test results are shown in Table 5.

[0155] Table 5 PCR detection

[0156]

[0157] Note: "+" indicates a positive PCR test result, "-" indicates a negative PCR test result, and "+-" indicates a weakly positive PCR test result. During the experiment, due to the small amount of African swine fever virus diluent used in the validation experiment, the symptoms were asymptomatic or mild, and no animals died.

[0158] As can be seen from Table 5, the breeding method of the present invention can effectively prevent African swine fever. For nursery pigs, since the immune system of nursery pigs has not yet fully developed and the time of feeding the drug preparation is short, the PCR test result is positive on the 4th day, but on the 7th day, the PCR test result turns weakly positive. Compared with the pigs fed with nursery pig feed not containing drug preparations, the pigs have obvious resistance to African swine fever virus and can effectively prevent and treat African swine fever; for fattening pigs, since the immune system of fattening pigs is fully developed and the time of feeding the drug preparation is long, the PCR test result is positive only on the 1st day, and then turns negative. Compared with the pigs fed with fattening pig feed not containing drug preparations, the pigs have obvious resistance to African swine fever virus and can effectively prevent and treat African swine fever.

[0159] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, ordinary technicians in the relevant field should understand that the specific implementation methods of the present invention can still be modified or replaced by equivalents. Any modification or equivalent replacement that does not depart from the spirit and scope of the present invention should be covered within the scope of protection of the claims of the present invention.

Claims

1. A breeding method for preventing and treating African swine fever, characterized in that: The following steps are involved: 1) mixing an astragalus extract, a codonopsis extract, an angelica extract, a soybean extract, a phellodendron chinense extract, an isatis indigotica extract and a viola yedoensis extract to obtain a pharmaceutical preparation; 2) adding the pharmaceutical preparation obtained in step 1) to nursery pig feed to obtain nursery pig feed for preventing and treating African swine fever; 3) using the nursery pig feed for preventing and treating African swine fever obtained in step 2) to feed the pigs that are about to enter the nursery period until the nursery period ends and they enter the fattening period; 4) adding the pharmaceutical preparation obtained in step 1) to fattening pig feed to obtain fattening pig feed for preventing and treating African swine fever; 5) Feeding fattening pigs with the fattening pig feed for preventing and treating African swine fever obtained in step 4) until the fattening period ends.

2. A breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 1), The extraction method of the astragalus extract comprises the following steps: using 50% ethanol as a solvent, according to the solid-liquid ratio of astragalus to 50% ethanol being 1:10, reflux extraction at 60° C. for 0.5 h, then concentrating by rotary evaporation, and drying to obtain the astragalus extract; The extraction method of the Codonopsis pilosula extract comprises the following steps: using 75% ethanol as a solvent, with a solid-liquid ratio of Codonopsis pilosula to 75% ethanol of 1:10, reflux extraction at 80° C. for 1 hour, then concentrating by rotary evaporation, and drying to obtain the Codonopsis pilosula extract; The extraction method of the angelica extract comprises the following steps: using 65% ethanol as a solvent, with a solid-liquid ratio of angelica to 65% ethanol of 1:15, reflux extraction at 60°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the angelica extract; The soybean extract extraction method comprises the following steps: using 75% ethanol as solvent, with a solid-liquid ratio of soybean to 75% ethanol of 1:20, reflux extraction at 55° C. for 2 hours, then concentrating by rotary evaporation, and drying to obtain the soybean extract; The extraction method of the Phellodendron chinense extract comprises the following steps: using 45% ethanol as a solvent, with a solid-liquid ratio of Phellodendron chinense to 45% ethanol of 1:15, reflux extraction at 70°C for 0.5h, then concentrating by rotary evaporation, and drying to obtain the Phellodendron chinense extract; The extraction method of the isatis indigotica extract comprises the following steps: using 75% ethanol as solvent, with a solid-liquid ratio of isatis indigotica to 75% ethanol of 1:10, reflux extraction at 65°C for 1.2h, then concentrating by rotary evaporation, and drying to obtain the isatis indigotica extract. The extraction method of the Viola yedoensis extract comprises the following steps: using 20% ​​ethanol as solvent, according to the solid-liquid ratio of Viola yedoensis to 20% ethanol being 1:10, reflux extraction at 40°C for 3h, then concentrating by rotary evaporation, and drying to obtain the Viola yedoensis extract.

3. A breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 1), the mass ratio of the astragalus extract, codonopsis extract, angelica extract, soybean extract, phellodendron chinense extract, isatis indigotica extract and viola yedoensis extract is 1:(2-4):(2-4):(4-6):(1-3):(2-4):(0.5-1.5).

4. A breeding method for preventing and treating African swine fever according to claim 3, characterized in that: The mass ratio of the astragalus extract, codonopsis pilosula extract, angelica extract, soybean extract, phellodendron amurense extract, isatis indigotica extract and viola yedoensis extract is 1:3:3:5:2:3:

1.

5. The breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 2), the mass ratio of the nursery pig feed to the drug preparation is (80-100):

1.

6. A breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 3), the feeding is carried out according to a feeding amount of (body weight×0.02) / day.

7. A breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 4), the mass ratio of the fattening pig feed to the pharmaceutical preparation is (40-50):

1.

8. The breeding method for preventing and treating African swine fever according to claim 1, characterized in that: In step 5), the feeding is carried out according to a feeding amount of (body weight×0.04) / day.